Valuation: Divi's Laboratories Limited

Market Cap 2,479B 25.62B 22.88B 21.28B 19.36B 36.55B 36.71B 256B 100B 1,264B 96.21B 94.1B 4,057B P/E 2027 *
75.9x
P/E 2028 * 62.9x
Enterprise Value 2,444B 25.26B 22.56B 20.98B 19.09B 36.04B 36.19B 253B 98.95B 1,246B 94.84B 92.77B 3,999B EV / Sales 2027 *
19.4x
EV / Sales 2028 * 16.2x
Free-Float
48%
Yield 2027 *
0.38%
Yield 2028 * 0.42%
1 day-0.19%
1 week+1.38%
Current month+0.33%
1 month+1.35%
3 months+34.36%
6 months+53.58%
Current year+45.83%
1 week 9,165
Extreme 9165
9,660
1 month 8,923
Extreme 8923
9,740
Current year 5,647.5
Extreme 5647.5
9,740
1 year 5,647.5
Extreme 5647.5
9,740
3 years 3,295.3
Extreme 3295.3
9,740
5 years 2,730
Extreme 2730
9,740
10 years 532.65
Extreme 532.65
9,740
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 49 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 49 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.06%+1.38%+42.20%+148.25% 25.62B
+0.83%+3.19%+41.49%+94.83% 1,051B
+1.93%+2.11%+37.08%+67.40% 630B
+1.49%+5.19%+19.94%+85.13% 489B
+2.26%+0.90%+69.32%+40.73% 359B
+1.45%+3.50%+23.29%+40.84% 344B
+1.17%+2.37%+13.47%+32.81% 272B
+0.89%+1.08%-6.13%+9.63% 246B
+1.82%+2.94%+42.99%+46.29% 224B
+2.77%+4.44%+29.01%+96.43% 187B
Average +1.44%+2.67%+31.27%+66.23% 382.93B
Weighted average by Cap. +1.46%+2.92%+33.42%+66.85%

Financials

2027 *2028 *
Net sales 126B 1.3B 1.16B 1.08B 984M 1.86B 1.87B 13.02B 5.1B 64.23B 4.89B 4.78B 206B 150B 1.55B 1.39B 1.29B 1.17B 2.21B 2.22B 15.51B 6.08B 76.52B 5.82B 5.7B 246B
Net income 32.7B 338M 302M 281M 255M 482M 484M 3.38B 1.32B 16.67B 1.27B 1.24B 53.5B 39.53B 408M 365M 339M 309M 583M 585M 4.08B 1.6B 20.16B 1.53B 1.5B 64.68B
Net Debt -35.11B -363M -324M -301M -274M -518M -520M -3.63B -1.42B -17.9B -1.36B -1.33B -57.44B -44.97B -465M -415M -386M -351M -663M -666M -4.65B -1.82B -22.93B -1.74B -1.71B -73.58B
Projected Income Statement - Annual - Divi's Laboratories Limited
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
12/10/26 ₹9,334.50 -0.06% 82,201
09/10/26 ₹9,340.00 -0.22% 378,861
08/10/26 ₹9,361.00 -2.37% 441,895
07/10/26 ₹9,588.00 +0.40% 422,217
06/10/26 ₹9,550.00 +3.85% 465,106
Trader
Investor
Global
Quality
ESG MSCI
BB
Ratings Surperformance© - Divi's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
9,340.00INR
Average target price
8,536.48INR
Spread / Average Target
-8.60%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Divi's Laboratories Limited
  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock